Clinical Research Directory
Browse clinical research sites, groups, and studies.
Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019)
Sponsor: The Methodist Hospital Research Institute
Summary
This pilot, prospective study will assess the safety and efficacy of COVID-19 convalescent plasma versus standard care as treatment for severe and/or critical COVID-19 (as defined in the inclusion criteria) in adults 18 years of age and older. A total of 350 eligible subjects will receive a transfusion of anti-SARS-CoV2 ( severe acute respiratory syndrome) convalescent plasma.
Official title: Convalescent Plasma for the Treatment of Coronavirus Disease 2019
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
350
Start Date
2020-03-20
Completion Date
2023-12-20
Last Updated
2026-04-29
Healthy Volunteers
No
Conditions
Interventions
COVID 19 Convalescent Plasma
COVID 19 convalescent plasma is a blood product collected from donors who have recovered from a previous COVID 19 infection
Locations (1)
Houston Methodist Hopsital
Houston, Texas, United States